Dov Gardin

Dov Gardin has a diverse work experience spanning multiple industries and roles. Dov is currently serving as the Vice President of Enterprise Risk Management at Catalent Pharma Solutions. In addition, they are an Advisory Council Member at the University of Maryland - Robert H. Smith School of Business and a member of the Advisory Board at Helix Decision Science.

Prior to these positions, Dov Gardin worked as the Managing Member at AIVEC Fund and held various roles at Regeneron, including Senior Director of Compliance Risk and Head of Global Resilience. Dov also worked as a Security Advisor at Gardin Consulting, where they advised clients on security measures and provided training.

Previous to that, they were the Director of Global Risk Management and Business Continuity at AbbVie and the Director and Head of Global Risk Management and Continuity at Allergan. Dov also served as a Director at Lootok, Ltd., where they managed global business continuity programs.

Lastly, Dov Gardin worked as a Consultant at Control Risks, where they supported Merck in threat intelligence and travel security, crisis management, and geopolitical risk assessments. Overall, Dov Gardin has a wealth of experience in risk management and security across different organizations and sectors.

Dov Gardin holds a Master of Arts degree in Security Studies from Georgetown University, which they completed from 2005 to 2007. Dov also obtained a Bachelor of Arts degree in Political Science and Business Management from the University of Michigan, where they studied from 1998 to 2001. Additionally, they undertook Middle East Studies at The Hebrew University of Jerusalem for the academic year 1999-2000. Dov Gardin has further certifications in Business Continuity (MBCI) from the Business Continuity Institute (BCI) in 2016 and in Certified Business Continuity Professional (CBCP) from DRI International in 2014.